Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Healthy Male Subjects
Clinical trial NCT05087069 · COMPLETED
Trial details
- NCT number
- NCT05087069
- Sponsor
- BioVersys SAS
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-08
- Primary completion
- 2022-04-08
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.